Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Breast Cancer Early Stage Breast Cancer (Stage 1-3) × fezolinetant × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 1 Hot Flashes 1 Carcinoma, Intraductal, Noninfiltrating 1 Breast Cancer Early Stage Breast Cancer (Stage 1-3) 1

Interventions

fezolinetant 1 Therapeutics 1 Immune Checkpoint Inhibitors 1 Anthracyclines 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06917313 2026-02-10

FLASH-Breast: Evaluating the Efficacy of Fezolinetant in Reducing Vasomotor Symptoms in Women With Breast Cancer on Endocrine Therapy

Yale University

Phase 2 Recruiting

Breast Cancer Early Stage Breast Cancer (Stage 1-3)

Data powered by HemOnc (CC BY 4.0) Colophon ⚡